Feline VDBP antibody and antigen (recombinant protein)

Diagnostic anti-Feline VDBP antibodies pairs and antigen for animal health (animal Cat/Feline liver failure, type I diabetes, cystic fibrosis) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-FEL-VDBP-Ag01 Recombinant Feline VDBP protein 3090
GMP-FEL-VDBP-Ab01 Anti-Feline VDBP mouse monoclonal antibody (mAb) 1953
GMP-FEL-VDBP-Ab02 Anti-Feline VDBP mouse monoclonal antibody (mAb) 1953
GMP-FEL-VDBP-Ab03 Anti-Feline VDBP human monoclonal antibody (mAb) 1953
GMP-FEL-VDBP-Ab04 Anti-Feline VDBP human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-FEL-VDBP-Ag01
Product Name Recombinant Feline VDBP protein
Target/Biomarker Feline vitamin D binding protein (sFlt-1)
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Feline vitamin D binding protein antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in sFlt-1 level test of animal Cat/Feline with liver failure, type I diabetes, cystic fibrosis.
Tag His
Products description Recombinant Feline VDBP protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-FEL-VDBP-Ab01, GMP-FEL-VDBP-Ab02
Product Name Anti-Feline VDBP mouse monoclonal antibody (mAb)
Target/Biomarker Feline vitamin D binding protein (sFlt-1)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Feline vitamin D binding protein antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-sFlt-1 antibodies in sFlt-1 level test of animal Cat/Feline with liver failure, type I diabetes, cystic fibrosis.
Tag mFc
Products description Anti-Feline VDBP mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-sFlt-1 antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-FEL-VDBP-Ab03, GMP-FEL-VDBP-Ab04
Product Name Anti-Feline VDBP human monoclonal antibody (mAb)
Target/Biomarker Feline vitamin D binding protein (sFlt-1)
Expression platform CHO
Isotypes Human IgG1
Bioactivity validation Recombinant Feline vitamin D binding protein antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-sFlt-1 antibodies in sFlt-1 level test of animal Cat/Feline with liver failure, type I diabetes, cystic fibrosis.
Tag hFc
Products description Anti-Feline VDBP human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-sFlt-1 antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    Vitamin D Binding Protein (VDBP) in cats, or felines, occupies a pivotal position in the intricate tapestry of feline physiology, orchestrating the complex symphony of vitamin D metabolism and transportation. This multifunctional protein, predominantly synthesized in the liver, plays an indispensable role in ensuring the efficient utilization of vitamin D, a vital fat-soluble nutrient for feline health. VDBP's primary role is that of a guardian of vitamin D, a crucial component of feline well-being. Vitamin D is a master regulator, orchestrating calcium homeostasis, bone health, and immune system function. However, this fat-soluble vitamin comes with unique transportation challenges. Vitamin D doesn't readily dissolve in water, making it challenging to navigate the aqueous environment of the bloodstream. Herein lies the remarkable function of VDBP. VDBP, acting as a faithful chaperone, binds to vitamin D and its metabolites, including calcidiol and calcitriol. This binding not only enhances the solubility of these compounds but also ensures their safe passage through the bloodstream to reach their intended destinations. These destinations include the intestines, where vitamin D is essential for calcium absorption, as well as the bones, where it supports bone mineralization, and immune cells, where it modulates the immune response. The importance of VDBP's transport function cannot be overstated. In the intestines, it facilitates calcium absorption, a cornerstone of skeletal health in cats. Calcium is a fundamental mineral for bone strength, muscle function, and overall body integrity, and its regulation is intricately tied to vitamin D. VDBP ensures that vitamin D is available in sufficient quantities to uphold calcium homeostasis, safeguarding bone integrity and overall feline well-being. Moreover, vitamin D plays a pivotal role in immune system function. It acts as an immunomodulator, helping to regulate the immune response. A deficiency in vitamin D can compromise the feline immune system, potentially leading to increased susceptibility to infections and other diseases. Beyond its role in vitamin D transport, VDBP has a fascinating facet - its immunomodulatory properties. VDBP can interact with immune cells and various cytokines, potentially influencing the immune response in cats. This aspect of VDBP's function broadens its significance beyond vitamin D regulation and invites exploration into its broader impact on feline health and immune-related conditions. The regulation of VDBP synthesis adds yet another layer of complexity. It is influenced by several factors, including vitamin D status, hormones, and genetic factors. When vitamin D levels are low, the production of VDBP increases, enhancing vitamin D transport and utilization. Conversely, when vitamin D levels are elevated, VDBP levels may decrease, serving as a regulatory mechanism to prevent excessive vitamin D activity and potential toxicity.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment